As of June 2022 Gilead Sciences has a market cap of $79.78 Billion. This makes Gilead Sciences the world's 155th most valuable company by market cap according to our data. The market capitalization, commonly called market cap, is the total market value of a publicly traded company's outstanding shares and is commonly used to measure how much a company is worth.
Year | Market cap | Change |
---|---|---|
2022 | $79.78 B | -12.38% |
2021 | $91.05 B | 24.68% |
2020 | $73.03 B | -11.22% |
2019 | $82.26 B | 2.59% |
2018 | $80.18 B | -14.31% |
2017 | $93.58 B | -0.81% |
2016 | $94.34 B | -34.43% |
2015 | $143.89 B | 1.84% |
2014 | $141.29 B | 22.62% |
2013 | $115.23 B | 106.55% |
2012 | $55.79 B | 81.47% |
2011 | $30.74 B | 5.78% |
2010 | $29.06 B | -25.35% |
2009 | $38.93 B | -16.39% |
2008 | $46.56 B | 8.95% |
2007 | $42.73 B | 42.74% |
2006 | $29.94 B | 23.89% |
2005 | $24.16 B | 53.89% |
2004 | $15.70 B | 26.36% |
2003 | $12.42 B | 84.99% |
2002 | $6.71 B | 5.91% |
2001 | $6.34 B |
On Jun 26th, 2022 the market cap of Gilead Sciences was reported to be:
Name | Market cap | Market cap differencediff. | Country |
---|---|---|---|
![]() Johnson & Johnson JNJ | $479.67 B | 501.21% | ๐บ๐ธ USA |
![]() Pfizer PFE | $289.46 B | 262.81% | ๐บ๐ธ USA |
![]() AbbVie ABBV | $269.20 B | 237.41% | ๐บ๐ธ USA |
![]() Eli Lilly LLY | $309.39 B | 287.78% | ๐บ๐ธ USA |
![]() Amgen AMGN | $131.07 B | 64.29% | ๐บ๐ธ USA |
![]() Biogen BIIB | $31.03 B | -61.10% | ๐บ๐ธ USA |
![]() Illumina ILMN | $30.46 B | -61.81% | ๐บ๐ธ USA |
![]() Vertex Pharmaceuticals VRTX | $74.82 B | -6.22% | ๐บ๐ธ USA |
![]() Merck MRK | $235.50 B | 195.18% | ๐บ๐ธ USA |